Adap.tv, acquired by AOL six months ago, unveiled on Monday a new add-on to its Audience Path demand-side platform (DSP), called Audience Path for TV, to let advertisers and agencies apply more data ...

Yesterday, Adap.tv announced a new platform it’s calling “Adap.tv for Advertisers,” which it describes as a buy-side management system for online video advertising. The company says Interpublic ...

Adaptimmune Therapeutics plc, a commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops TECELRA ...

In addition to solid earnings, AOL is reporting this morning that it has acquired Adap.tv for $405 million. It's a smart acquisition. The fastest-growing, healthiest part of AOL's business is AOL ...

Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) shares are trading higher by 15.8% to $1.17 during Friday’s session after the company and Galapagos entered a clinical collaboration to license ...

Adaptimmune Therapeutics PLC ADR Annual stock financials by MarketWatch. View the latest ADAP financial statements, income statements and financial ratios.

After the market closed on 3/24/25, Adaptimmune (NASDAQ:ADAP) filed the company’s Form 10-K Annual Report. ADAP reported a net loss of $74.2 million for 4Q24, or $(0.05) per diluted ordinary share ...

The combined announcements had YuMe chief marketing officer Ed Haslam excited as he spoke from the NYSE building following an opening bell ceremony and breakfast for employees, customers and investors ...

The online media company can thank its takeover of Adap.tv and video ads for an acceleration in revenue, but it barely eked out a profit because of cutbacks at local news site Patch. Joan E. Solsman ...

Adaptimmune Therapeutics ADAP is a clinical-stage biopharmaceutical company focused on developing novel T-cell therapies targeting cancer indications. The most advanced candidate in the company’s ...

AOL on Wednesday said it has agreed to acquire online video advertising company Adap.tv, whose software matches advertising buyers and sellers, for $405 million, its biggest deal under its current ...

Adaptimmune Therapeutics plc ADAP announced entering into a transition agreement with GSK plc GSK to ensure the return of rights and materials comprised within the PRAME and NY-ESO cell therapy ...